CryoMass Technologies Inc. announced the successful transition from beta testing to commercial-level processing of its Trichome Separation Beta unit, also known as "CryoSift Separator". Since acquiring all intellectual property from CryoCann USA Corp, CryoMass has achieved remarkable strides in advancing and protecting its proprietary technology. Prior to the CryoCann asset acquisition, the technology had undergone six years of intensive research and development, but it had not been validated at an industrial scale.

CryoMass has now achieved a major milestone by successfully designing and constructing an industrial-scale Beta system, which has undergone rigorous testing across multiple phases. This comprehensive journey, starting from the initial industrial design to the completion and testing of the first prototype, hasaid a solid foundation for CryoMass to embark on commercial-level processing. This achievement marks a significant leap forward for the Company.

Following the completion of the CryoSift Separator Beta unit's build, CryoMass initially installed the unit at RedTape Core Partners LLC's licensed Coastal Refinement Solutions ("Coastal"), California, processing center in mid-December, pursuant to a multi-state licensing agreement that previously announced CryoMass, in collaboration with Coastal's extraction team, conducted trial runs on the Beta unit and identified areas for optimization to enhance performance. After completing the necessary modifications, a second series of biomass test runs began. During the second series of runs, the company focussed on evaluating the system's reliability, performance, and safety, established optimal cleaning and maintenance procedures, and determined the final design for the first serialized CryoSift Separator build.

The company also captured efficiency data and started to establish Standard Operating Procedures (SOPs) for processing CryoSift (trichomes separated using the Company‘s proprietary method) in either a hydrocarbon-based extraction system or for producing solventless extracts. Throughout this phase, the CryoMass team closely monitored stress points, and performed necessary maintenance and adjustments during periods of downtime.